January 30, 2015 2:57 AM ET


Company Overview of Allakos Inc.

Company Overview

Allakos Inc., a biotechnology company, develops antibody-based therapeutics to treat diseases in which dysregulation of the T-helper type 2 immune response plays a key role in pathology, including allergic disease, inflammation, and diseases characterized by excess production of inflammatory cells. Its antibodies target cell types implicated in allergic and inflammatory responses. Allakos Inc. was founded in 2012 and is based in San Mateo, California.

132 Avila Road

San Mateo, CA 94402

United States

Founded in 2012



Key Executives for Allakos Inc.

Co-Founder and Vice President of Research
Chief Medical Officer
Age: 53
Compensation as of Fiscal Year 2014.

Allakos Inc. Key Developments

Allakos Inc. Appoints Alejandro Dorenbaum as Chief Medical Officer

Allakos Inc. announced the appointment of Alejandro Dorenbaum as Chief Medical Officer. At BioMarin Pharmaceutical Inc., he was responsible for the clinical development of Kuvan(R), and at Genentech, he was responsible for the respiratory programs in asthma and cystic fibrosis. Dr. Dorenbaum also served as Chief Medical Officer at Lumena Pharmaceutical until its acquisition by Shire.

Similar Private Companies By Industry

Company Name Region
Principia Biopharma Inc. United States
Spinnaker Biosciences, Inc. United States
Cresco Labs, LLC United States
Stem Genetics Inc United States
Ampla Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Allakos Inc., please visit www.allakos.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.